---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-25-000018"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T17:30:44.718863+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Q1 rev $201.3M (+23% YoY), EPS $0.10; raises FY EPS guidance to $2.20-$2.30

## Summary
- Revenue $201.3M, up 23% YoY; U.S. revenue $193.6M (+24%), OUS $7.7M (-6%).
- Net income $3.0M (diluted EPS $0.10) vs net loss $10.0M ($0.34 loss) in Q1 2024.
- Adjusted EBITDA $33.2M, up from $11.9M; operating loss improved 90% to $1.5M.
- Surpassed 100,000 patients on Inspire therapy; Inspire V system launch starting in U.S. May 2025.
- FY 2025 revenue guidance maintained $940-955M; EPS guidance raised to $2.20-$2.30 (from $2.10-$2.20).

## SEC filing metadata
- accession: 0001609550-25-000018
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000018/0001609550-25-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000018/insp-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-25-000018
- JSON: https://secwatch.observer/filing/0001609550-25-000018.json
- Plain text: https://secwatch.observer/filing/0001609550-25-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.